leisure time -WSS

leisure time

author：entertainment 2025-09-28 21:58:38 - browse：3

Person wearing a smart watch. -- first opinion coverage from STAT — Adobe

The Apple Watch has secured a new qualification from the Food and Drug Administration that could make the smartwatch an appealing tool for medical device companies hoping to illustrate the benefits of a common heart procedure.

Last week, the Apple Watch’s Atrial Fibrillation History feature became the first digital tool qualified under the Medical Device Development Tools (MDDT) program. Released in 2022, the feature estimates a user’s A-fib burden, or how much time they spend in atrial fibrillation, which is an irregular heart rhythm that can cause shortness of breath and fatigue, and is also linked to an increased risk of stroke.

The qualification means that FDA has determined in advance that sponsors can use the feature as a secondary endpoint in clinical trials without having to do additional work. Specifically, the Apple Watch is qualified for use as a secondary endpoint in clinical trials for cardiac ablation devices, which reduce the electrical signals that cause A-fib by scarring the heart with extreme heat or cold energy. Pulsed field ablation is the latest version of the technology, using a controlled electric field to scar tissue rather than the riskier thermal energy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Wikipedia

WSS

Digital health: a case of mistaken identity

H5N1 virus can be tracked in retail milk, scientists say

At flashy new research hub, AstraZeneca lays out ambitious growth goals

H5N1 virus can be tracked in retail milk, scientists say

Senate panel passes drug pricing bills, but drops one PBM reform

Novo: Oral version of Ozempic leads to 15% weight loss

knowledge

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

entertainment

Psychedelics group wrestles with new pharma identity

FDA poised to publish guidelines for clinical trial diversity

In Memoriam: Notable people who died in 2023

Millions may soon lose Medicaid when they don't have to

Alkermes shareholders re

Millions may soon lose Medicaid when they don't have to

Virginia high school admissions case could be legal follow

Living organ donors deserve priority status for transplants

FDA approval of Sarepta Duchenne genetic therapy gives me hope

FDA poised to publish guidelines for clinical trial diversity

focus

Biogen nominates mother of director’s child to replace him on board

Patients, doctors are clashing about side effects of hormonal birth control

Novo: Oral version of Ozempic leads to 15% weight loss

The thinking behind the controversial eating disorder chatbot Tessa

A public health expert passes on football's full body collisions for youths

Bispecific antibodies are next new thing in cancer immunotherapy

knowledge

explore

Wikipedia

entertainment